Literature DB >> 12867211

Is opiate detoxification unsafe in pregnancy?

Jason Luty1, Vasilis Nikolaou, Jenny Bearn.   

Abstract

Despite the widespread avoidance of detoxification in the second or third trimesters, there is no clear evidence to support the view that methadone withdrawal is harmful in pregnant opiate dependent women. We investigated the safety of methadone detoxification in pregnancy in a retrospective case series of 101 pregnant opiate dependent women who underwent a 21-day in-patient methadone withdrawal. One miscarriage occurred in the first trimester (n = 5; incidence rate ratio of 6.87 compared to population norms (95% CI = 0.16-47.3; p =.15)). No miscarriages were observed in the second trimester (n = 54; incidence rate ratio = 0 compared to population norms (95% CI = 0-3.69; p =.27). One premature delivery occurred in the third trimester (1 in 158 weeks at risk compared to 1 in 150 weeks in population norms; p =.16). Methadone detoxification treatment was not associated with any increased risk of miscarriage in the second trimester or premature delivery in the third trimester.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12867211     DOI: 10.1016/s0740-5472(03)00035-7

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  20 in total

Review 1.  Pharmacological Management of Opioid Use Disorder in Pregnant Women.

Authors:  Christine M Wilder; Theresa Winhusen
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

2.  Cocaine and opioid use during pregnancy: prevalence and management.

Authors:  Chaya G Bhuvaneswar; Grace Chang; Lucy A Epstein; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

Review 3.  Pregnancy and injecting drug use.

Authors:  James Bell; Lucy Harvey-Dodds
Journal:  BMJ       Date:  2008-06-07

4.  Treatment of Prescription Opioid Use Disorder in Pregnant Women.

Authors:  Constance Guille; Kelly S Barth; Julio Mateus; Jenna L McCauley; Kathleen T Brady
Journal:  Am J Psychiatry       Date:  2017-03-01       Impact factor: 18.112

Review 5.  The management of opioid dependence during pregnancy in rural and remote settings.

Authors:  Naana Afua Jumah; Lisa Graves; Meldon Kahan
Journal:  CMAJ       Date:  2014-10-06       Impact factor: 8.262

Review 6.  Risk Factors Associated with the Occurrence of Neonatal Opioid Withdrawal Syndrome: A Review.

Authors:  Erin Kelty; David B Preen
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

Review 7.  The treatment of alcohol and opioid dependence in pregnant women.

Authors:  Annemarie Heberlein; Lorenzo Leggio; Dirk Stichtenoth; Thomas Hillemacher
Journal:  Curr Opin Psychiatry       Date:  2012-11       Impact factor: 4.741

Review 8.  Evaluation and management of opioid dependence in pregnancy.

Authors:  Eliza M Park; Samantha Meltzer-Brody; Joji Suzuki
Journal:  Psychosomatics       Date:  2012-08-14       Impact factor: 2.386

9.  Relationship between cigarette use and mood/anxiety disorders among pregnant methadone-maintained patients.

Authors:  Margaret S Chisolm; Michelle Tuten; Emily C Brigham; Eric C Strain; Hendrée E Jones
Journal:  Am J Addict       Date:  2009 Sep-Oct

10.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.